333 followers
RT @FrontNeurol: New Research: Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate…
RT @FrontNeurol: New Research: Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate…
New Research: Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate: Background: Clinically stable multiple sclerosis (MS) patients on long-term therapy often have negligible acute… https://t.co/hnrJ7b